One paper to be presented at the upcoming annual meeting of the American Urological Association (AUS) gives results from treatment with a 3-month dose of androgen deprivation therapy (ADT) for men with low-risk prostate cancer compared to standard active surveillance. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: ac tive, ADT, leuprolide, low risk, outcome, short-term, surveillance, trial | 9 Comments »
A newly published article in European Urology has raised a new issue that should be of significant concern to urologists (and to their patients) in relation to risks associated with the possibility of diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, complication, incidence, rates, short-term | Leave a comment »
Well here’s a good idea! Let’s actually ask patients what they think about the pros and cons of long- and short-term hormone therapy in association with radiation! … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: androgen deprivation therapy, long-term, radiation, short-term | 6 Comments »
A report published by Reuters within the past couple of hours makes some surprisingly assertive claims about the safety of (unspecified forms of) “radiation therapy” in the treatment of prostate cancer. These claims are all the worse for being based on retrospective analysis as opposed to any sort of prospective clinical trial. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse events, radiation therapy, short-term, surgery | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 